Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Guasch Ferré, Marta ^a   Merino, Jordi ^b   Sun, Qi ^a,c   Fitó, Montse ^d,e   Salas Salvadó, Jordi ^e,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HOSPITAL DEL MAR   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOIDS; INSULIN; OLIVE OIL;

BENEFICIAL EFFECTS; BIOACTIVE COMPOUNDS; DIFFERENT MECHANISMS; GENETIC PREDISPOSITION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDITERRANEAN DIET; METABOLIC BIOMARKERS;

OILS AND FATS;

BIOLOGICAL MARKER; EXTRA VIRGIN OLIVE OIL; FLAVAN 3 OL; OLIVE OIL; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; POLYPHENOL;

CARDIOMETABOLIC RISK; GENE INTERACTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDITERRANEAN DIET; METAGENOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUT; NUTRITION; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RED WINE; REVIEW; DIET THERAPY; METABOLISM;

DISEASES; FRUITS; VEGETABLES;

DIABETES MELLITUS, TYPE 2; DIET, MEDITERRANEAN; HUMANS; INSULIN RESISTANCE; POLYPHENOLS; PREDIABETIC STATE;

EID: 85028663979     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/6723931     Document Type: Review

References (94)

1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 7th edition, 2015.
2. L. Chen, D. J. Magliano, and P. Z. Zimmet, "The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives," Nature Reviews Endocrinology, vol. 8, pp. 228-236, 2012.
3. U.S. Department of Agriculture and U.S. Department of Helath and Human Services, Scientific Report of the 2015 Dietary Guidelines Advisory Committee, US Departmentof Health and Human Services, Washington (DC), 2015.
4. A. Satija, S. N. Bhupathiraju, E. B. Rimm et al., "Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies," PLoS Medicine, vol. 13, article e1002039, 2016.
5. M. A. Martínez-González, J. Salas-Salvadó, R. Estruch, D. D. Corella, M. Fitó, and E. Ros, "Benefits of the Mediterranean diet: insights from the PREDIMED study," Progress in Cardiovascular Diseases, vol. 58, pp. 50-60, 2015.
6. O. Rangel-Huerta, B. Pastor-Villaescusa, C. Aguilera, and A. Gil, "A systematic review of the efficacy of bioactive compounds in cardiovascular disease: phenolic compounds," Nutrients, vol. 7, pp. 5177-5216, 2015.
7. K. B. Pandey and S. I. Rizvi, "Plant polyphenols as dietary antioxidants in human health and disease," Oxidative Medicine and Cellular Longevity, vol. 2, pp. 270-278, 2009.
8. J. Pérez-Jiménez, V. Neveu, F. Vos, and A. Scalbert, "Identification of the 100 richest dietary sources of polyphenols: an application of the phenol-explorer database," European Journal of Clinical Nutrition, vol. 64, Supplement 3, pp. S112-S120, 2010.
9. A. Scalbert, C. Manach, C. Morand, C. Rémésy, and L. Jiménez, "Dietary polyphenols and the prevention of diseases," Critical Reviews in Food Science and Nutrition, vol. 45, pp. 287-306, 2005.
10. C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez, "Polyphenols: food sources and bioavailability," The American Journal of Clinical Nutrition, vol. 79, pp. 727-747, 2004.
11. N. M. Wedick, A. Pan, A. Cassidy et al., "Dietary flavonoid intakes and risk of type 2 diabetes in US men and women," The American Journal of Clinical Nutrition, vol. 95, pp. 925-933, 2012.
12. Q. Sun, N. M. Wedick, A. Pan et al., "Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women," Diabetes Care, vol. 37, pp. 1287-1295, 2014.
13. A. Tresserra-Rimbau, M. Guasch-Ferre, J. Salas-Salvado et al., "Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk," The Journal of Nutrition, vol. 146, pp. 767-777, 2016.
14. M. G. Shrime, S. R. Bauer, A. C. McDonald, N. H. Chowdhury, C. E. M. Coltart, and E. L. Ding, "Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies," The Journal of Nutrition, vol. 141, pp. 1982-1988, 2011.
15. L. Hooper, C. Kay, A. Abdelhamid et al., "Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials," The American Journal of Clinical Nutrition, vol. 95, pp. 740-751, 2012.
16. P. J. Curtis, M. Sampson, J. Potter, K. Dhatariya, P. A. Kroon, and A. Cassidy, "Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, doubleblind, randomized, controlled trial," Diabetes Care, vol. 35, pp. 226-232, 2012.
17. X.-X. Zheng, Y.-L. Xu, S.-H. Li, R. Hui, Y.-J. Wu, and X.-H. Huang, "Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials," The American Journal of Clinical Nutrition, vol. 97, pp. 750-762, 2013.
18. A. J. Stull, K. C. Cash, W. D. Johnson, C. M. Champagne, and W. T. Cefalu, "Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women," The Journal of Nutrition, vol. 140, pp. 1764-1768, 2010.
19. P.-W. Zhang, F.-X. Chen, D. Li, W.-H. Ling, and H.-H. Guo, "A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease," Medicine (Baltimore), vol. 94, article e758, 2015.
20. A. Basu, N. M. Betts, A. Nguyen, E. D. Newman, D. Fu, and T. J. Lyons, "Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids," The Journal of Nutrition, vol. 144, pp. 830-837, 2014.
21. Z.-M. Liu, Y.-M. Chen, and S. C. Ho, "Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials," The American Journal of Clinical Nutrition, vol. 93, pp. 1092-1101, 2011.
22. E. Ricci, S. Cipriani, F. Chiaffarino, M. Malvezzi, and F. Parazzini, "Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women," Menopause, vol. 17, pp. 1080-1086, 2010.
23. Y. Rhee and A. Brunt, "Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design," Nutrition Journal, vol. 10, p. 44, 2011.
24. A. Lemay, S. Dodin, N. Kadri, H. Jacques, and J.-C. Forest, "Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women," Obstetrics and Gynecology, vol. 100, pp. 495-504, 2002.
25. A. Pan, J. Sun, Y. Chen et al., "Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial," PLoS One, vol. 2, article e1148, 2007.
26. A. Pan, W. Demark-Wahnefried, X. Ye et al., "Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients," The British Journal of Nutrition, vol. 101, p. 1145, 2009.
27. S. M. Cornish, P. D. Chilibeck, L. Paus-Jennsen et al., "A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults," Applied Physiology, Nutrition, and Metabolism, vol. 34, pp. 89-98, 2009.
28. A. Javidi, H. Mozaffari-Khosravi, A. Nadjarzadeh, A. Dehghani, and M. H. Eftekhari, "The effect of flaxseed powder on insulin resistance indices and blood pressure in prediabetic individuals: a randomized controlled clinical trial," Journal of Research in Medical Sciences, vol. 21, p. 70, 2016.
29. S. M. Madevan der, J. Plat, and R. P. Mensink, "Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial," PLoS One, vol. 10, article e0118393, 2015.
30. A. E. Dijkvan, M. R. Olthof, J. C. Meeuse, E. Seebus, R. J. Heine, and R. M. Damvan, "Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance," Diabetes Care, vol. 32, pp. 1023-1025, 2009.
31. V. Lecoultre, G. Carrel, L. Egli et al., "Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men," The American Journal of Clinical Nutrition, vol. 99, pp. 268-275, 2014.
32. K. Kempf, C. Herder, I. Erlund et al., "Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial," The American Journal of Clinical Nutrition, vol. 91, pp. 950-957, 2010.
33. N. M. Wedick, A. M. Brennan, Q. Sun, F. B. Hu, C. S. Mantzoros, and R. M. Damvan, "Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial," Nutrition Journal, vol. 10, p. 93, 2011.
34. "COcoa Supplement and Multivitamin Outcomes Study (COSMOS)," https://www.clinicaltrials.gov/ct2/show/NCT02 422745, 2016.
35. Y.-J. Liu, J. Zhan, X.-L. Liu, Y. Wang, J. Ji, and Q.-Q. He, "Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies," Clinical Nutrition, vol. 33, pp. 59-63, 2014.
36. R. Zamora-Ros, N. G. Forouhi, S. J. Sharp et al., "The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study," Diabetes Care, vol. 36, pp. 3961-3970, 2013.
37. P. F. Jacques, A. Cassidy, G. Rogers, J. J. Peterson, J. B. Meigs, and J. T. Dwyer, "Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes," The Journal of Nutrition, vol. 143, pp. 1474-1480, 2013.
38. P. Knekt, J. Kumpulainen, R. Järvinen et al., "Flavonoid intake and risk of chronic diseases," The American Journal of Clinical Nutrition, vol. 76, pp. 560-568, 2002.
39. Y. Song, J. E. Manson, J. E. Buring, H. D. Sesso, and S. Liu, "Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis," Journal of the American College of Nutrition, vol. 24, pp. 376-384, 2005.
40. M. K. Kataja-Tuomola, J. P. Kontto, S. Männistö, D. Albanes, and J. Virtamo, "Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers," European Journal of Clinical Nutrition, vol. 65, pp. 590-597, 2011.
41. R. Zamora-Ros, N. G. Forouhi, S. J. Sharp et al., "Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations," The Journal of Nutrition, vol. 144, pp. 335-343, 2014.
42. M. Ding, A. Pan, J. E. Manson et al., "Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts," European Journal of Clinical Nutrition, vol. 70, pp. 1381-1387, 2016.
43. M. Bulló, R. Lamuela-Raventós, and J. Salas-Salvadó, "Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants," Current Topics in Medicinal Chemistry, vol. 11, pp. 1797-1810, 2011.
44. A. Medina-Remón, R. Casas, A. Tressserra-Rimbau et al., "PREDIMED study investigators: polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial," British Journal of Clinical Pharmacology, vol. 83, pp. 114-128, 2017.
45. R. Estruch, M. A. Martínez-González, D. Corella et al., "Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial," Annals of Internal Medicine, vol. 145, pp. 1-11, 2006.
46. J. Salas-Salvadó, M. Bulló, R. Estruch et al., "Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial," Annals of Internal Medicine, vol. 160, pp. 1-10, 2014.
47. E. Ros, "Olive oil and CVD: accruing evidence of a protective effect," The British Journal of Nutrition, vol. 108, pp. 1931-1933, 2012.
48. S. Martín-Peláez, M. I. Covas, M. Fitó, A. Kušar, and I. Pravst, "Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims," Molecular Nutrition & Food Research, vol. 57, pp. 760-771, 2013.
49. M. Bockde, J. G. B. Derraik, C. M. Brennan et al., "Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial," PLoS One, vol. 8, article e57622, 2013.
50. J. Wainstein, T. Ganz, M. Boaz et al., "Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats," Journal of Medicinal Food, vol. 15, pp. 605-610, 2012.
51. S. Silva, M. R. Bronze, M. E. Figueira et al., "Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study," The American Journal of Clinical Nutrition, vol. 101, pp. 44-54, 2015.
52. C. Santangelo, C. Filesi, R. Varì et al., "Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin," Journal of Endocrinological Investigation, vol. 39, pp. 1295-1301, 2016.
53. A. Lasa, J. Miranda, M. Bulló et al., "Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes," European Journal of Clinical Nutrition, vol. 68, pp. 767-772, 2014.
54. M.-I. Covas, K. Nyyssönen, H. E. Poulsen et al., "The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial," Annals of Internal Medicine, vol. 145, pp. 333-341, 2006.
55. V. Konstantinidou, O. Khymenets, M.-I. Covas et al., "Time course of changes in the expression of insulin sensitivityrelated genes after an acute load of virgin olive oil," Omics, vol. 13, pp. 431-438, 2009.
56. P. Casas-Agustench, P. Lopez-Uriarte, M. Bullo, E. Ros, J. J. Cabre-Vila, and J. Salas-Salvado, "Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome," Nutrition, Metabolism, and Cardiovascular Diseases, vol. 21, pp. 126-135, 2011.
57. C. Luo, Y. Zhang, Y. Ding et al., "Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis," The American Journal of Clinical Nutrition, vol. 100, pp. 256-269, 2014.
58. I. Kang, T. Buckner, N. F. Shay, L. Gu, and S. Chung, "Improvements in metabolic health with consumption of Ellagic acid and subsequent conversion into urolithins: evidence and mechanisms," Advances in Nutrition: An International Review Journal, vol. 7, pp. 961-972, 2016.
59. X. Mora-Cubillos, S. Tulipani, M. Garcia-Aloy, M. Bulló, F. J. Tinahones, and C. Andres-Lacueva, "Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome," Molecular Nutrition & Food Research, vol. 59, pp. 2480-2490, 2015.
60. M. M. Marcadenti, M. Markoski, J. Garavaglia, A. Oliveira, and J. Olivaes, "Molecular properties of red wine compounds and cardiometabolic benefits," Nutrition and Metabolic Insights, vol. 9, p. 51, 2016.
61. G. Chiva-Blanch, M. Urpi-Sarda, E. Ros et al., "Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial," Clinical Nutrition, vol. 32, pp. 200-206, 2013.
62. R. Napoli, D. Cozzolino, V. Guardasole et al., "Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients," Metabolism, vol. 54, pp. 306-313, 2005.
63. P. Castilla, R. Echarri, A. Dávalos et al., "Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects," The American Journal of Clinical Nutrition, vol. 84, pp. 252-262, 2006.
64. L. Cordain, C. L. Melby, A. E. Hamamoto et al., "Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women," Metabolism, vol. 49, pp. 1473-1478, 2000.
65. J. W. J. Beulens, R. M. Beersvan, R. P. Stolk, G. Schaafsma, and H. F. J. Hendriks, "The effect of moderate alcohol consumption on fat distribution and adipocytokines," Obesity (Silver Spring), vol. 14, pp. 60-66, 2006.
66. M. Hokayem, E. Blond, H. Vidal et al., "Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients," Diabetes Care, vol. 36, pp. 1454-1461, 2013.
67. S. Timmers, E. Konings, L. Bilet et al., "Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans," Cell Metabolism, vol. 14, pp. 612-622, 2011.
68. Y. Gepner, R. Golan, I. Harman-Boehm et al., "Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial," Annals of Internal Medicine, vol. 163, pp. 569-579, 2015.
69. L. Mamluk, M. G. O'Doherty, P. Orfanos et al., "Fruit and vegetable intake and risk of incident of type 2 diabetes: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES)," European Journal of Clinical Nutrition, vol. 71, pp. 83-91, 2017.
70. Y. Kim, J. B. Keogh, and P. M. Clifton, "Polyphenols and glycemic control," Nutrients, vol. 8, p. 17, 2016.
71. K. Hanhineva, R. Törrönen, I. Bondia-Pons et al., "Impact of dietary polyphenols on carbohydrate metabolism," International Journal of Molecular Sciences, vol. 11, pp. 1365-1402, 2010.
72. G. Berná, M. J. Oliveras-López, E. Jurado-Ruíz et al., "Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis," Nutrients, vol. 6, pp. 5338-5369, 2014.
73. P. V. A. Babu, D. Liu, and E. R. Gilbert, "Recent advances in understanding the anti-diabetic actions of dietary flavonoids," The Journal of Nutritional Biochemistry, vol. 24, pp. 1777-1789, 2013.
74. J. K. Lee, K. Kim, Y. Ahn, M. Yang, and J. E. Lee, "Habitual coffee intake, genetic polymorphisms, and type 2 diabetes," European Journal of Endocrinology, vol. 172, pp. 595-601, 2015.
75. P. Palatini, E. Benetti, L. Mos et al., "Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients," European Journal of Epidemiology, vol. 30, pp. 209-217, 2015.
76. InterAct Consortium, "Investigation of gene-diet interactions in the incretin system and risk of type 2 diabetes: the EPICInterAct study," Diabetologia, vol. 59, pp. 2613-2621, 2016.
77. D. Corella, P. Carrasco, J. V. Sorli et al., "Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population," Diabetes Care, vol. 36, pp. 3803-3811, 2013.
78. Grant SFA, G. Thorleifsson, I. Reynisdottir et al., "Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes," Nature Genetics, vol. 38, pp. 320-323, 2006.
79. Y. Zhou, S.-Y. Park, J. Su et al., "TCF7L2 is a master regulator of insulin production and processing," Human Molecular Genetics, vol. 23, pp. 6419-6431, 2014.
80. R. D. Beger, W. Dunn, M. A. Schmidt et al., "Metabolomics enables precision medicine: "a white paper, community perspective"," Metabolomics, vol. 12, p. 149, 2016.
81. Q. Sun, N.M.Wedick, S. S.Tworoger et al., "Urinary excretion of select dietary polyphenol metabolites is associated with a lower risk of type 2 diabetes in proximate but not remote follow-up in a prospective investigation in 2 cohorts of US women," The Journal of Nutrition, vol. 145, pp. 1280-1288, 2015.
82. M. Ding, A. A. Franke, B. A. Rosner et al., "Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women," The British Journal of Nutrition, vol. 114, pp. 1694-1701, 2015.
83. J. Zhao, Y. Zhu, N. Hyun et al., "Novel metabolic markers for the risk of diabetes development in American Indians," Diabetes Care, vol. 38, pp. 220-227, 2015.
84. K.-P. Ko, C.-S. Kim, Y. Ahn et al., "Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study," Diabetologia, vol. 58, pp. 726-735, 2015.
85. X. Guo, A. Tresserra-Rimbau, R. Estruch et al., "Effects of polyphenol, measured by a biomarker of total polyphenols in urine, on cardiovascular risk factors after a long-term followup in the PREDIMED study," Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2572606, 11 pages, 2016.
86. A. H. Lee, L'. Tan, N. Hiramatsu et al., "Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women," Nutrition & Diabetes, vol. 6, article e212, 2016.
87. M. Eichholzer, A. Richard,H. L.Nicastro, E. A. Platz, J. Linseisen, and S. Rohrmann, "Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008," Cancer Causes & Control, vol. 25, pp. 395-403, 2014.
88. T. Struja, A. Richard, J. Linseisen, M. Eichholzer, and S. Rohrmann, "The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES," European Journal of Nutrition, vol. 53, pp. 1371-1381, 2014.
89. C. Xu, Q. Liu, Q. Zhang, A. Gu, and Z.-Y. Jiang, "Urinary enterolactone is associated with obesity and metabolic alteration in men in the US National Health and Nutrition Examination Survey 2001-10," The British Journal of Nutrition, vol. 113, pp. 683-690, 2015.
90. J. Qin, Y. Li, Z. Cai et al., "A metagenome-wide association study of gut microbiota in type 2 diabetes," Nature, vol. 490, pp. 55-60, 2012.
91. S. Moco, F.-P. J. Martin, and S. Rezzi, "Metabolomics view on gut microbiome modulation by polyphenol-rich foods," Journal of Proteome Research, vol. 11, pp. 4781-4790, 2012.
92. S. Martín-Peláez, J. I. Mosele, N. Pizarro et al., "Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota," European Journal of Nutrition, vol. 56, pp. 119-131, 2017.
93. V. Fogliano, M. L. Corollaro, P. Vitaglione et al., "In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction," Molecular Nutrition & Food Research, vol. 55, Supplement 1, pp. S44-S55, 2011.
94. X. Tzounis, A. Rodriguez-Mateos, J. Vulevic, G. R. Gibson, C. Kwik-Uribe, and J. P. Spencer, "Prebiotic evaluation of cocoaderived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study," The American Journal of Clinical Nutrition, vol. 93, pp. 62-72, 2011.